WO2014147641A3 - Sitagliptin pterostilbene phosphate salt, process for the preparation and pharmaceutical composition thereof - Google Patents

Sitagliptin pterostilbene phosphate salt, process for the preparation and pharmaceutical composition thereof Download PDF

Info

Publication number
WO2014147641A3
WO2014147641A3 PCT/IN2014/000150 IN2014000150W WO2014147641A3 WO 2014147641 A3 WO2014147641 A3 WO 2014147641A3 IN 2014000150 W IN2014000150 W IN 2014000150W WO 2014147641 A3 WO2014147641 A3 WO 2014147641A3
Authority
WO
WIPO (PCT)
Prior art keywords
sitagliptin
preparation
pharmaceutical composition
phosphate salt
pterostilbene phosphate
Prior art date
Application number
PCT/IN2014/000150
Other languages
French (fr)
Other versions
WO2014147641A2 (en
Inventor
Satyanarayana Chava
Seeta Ramanjaneyulu Gorantla
Venkata Sunil Kumar Indukuri
Ashwini Nangia
Krishna Sumanth Peraka
Udaya Bhaskara Rao KHANDAVILLI
Original Assignee
Laurus Labs Private Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laurus Labs Private Limited filed Critical Laurus Labs Private Limited
Publication of WO2014147641A2 publication Critical patent/WO2014147641A2/en
Publication of WO2014147641A3 publication Critical patent/WO2014147641A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to Sitagliptin Pterostilbene phosphate salt and its polymorphic forms, a process for its preparation. The present invention also relates to a pharmaceutical composition using the Sitagliptin Pterostilbene phosphate and its polymorphic forms.
PCT/IN2014/000150 2013-03-21 2014-03-07 Sitagliptin pterostilbene phosphate salt, process for the preparation and pharmaceutical composition thereof WO2014147641A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1230/CHE/2013 2013-03-21
IN1230CH2013 2013-03-21

Publications (2)

Publication Number Publication Date
WO2014147641A2 WO2014147641A2 (en) 2014-09-25
WO2014147641A3 true WO2014147641A3 (en) 2014-12-24

Family

ID=51581563

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2014/000150 WO2014147641A2 (en) 2013-03-21 2014-03-07 Sitagliptin pterostilbene phosphate salt, process for the preparation and pharmaceutical composition thereof

Country Status (1)

Country Link
WO (1) WO2014147641A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021249364A1 (en) 2020-06-12 2021-12-16 Wang, Jinping Novel analogs of pterostilbene amino acid bearing carbonates for treating a non-alcoholic fatty liver disease and nonalcoholic steatohepatitis

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005003135A1 (en) * 2003-06-24 2005-01-13 Merck & Co., Inc. Phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor
WO2005020920A2 (en) * 2003-09-02 2005-03-10 Merck & Co., Inc. Novel crystalline forms of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor
WO2005030127A2 (en) * 2003-09-23 2005-04-07 Merck & Co., Inc. Novel crystalline form of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor
WO2006033848A1 (en) * 2004-09-15 2006-03-30 Merck & Co., Inc. Amorphous form of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor
WO2011097372A2 (en) * 2010-02-03 2011-08-11 Aptuit Laurus Private Limited Pterostilbene cocrystals
CN103408591A (en) * 2013-07-17 2013-11-27 张家港威胜生物医药有限公司 Pterostilbene phosphate disodium salt synthesis method

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005003135A1 (en) * 2003-06-24 2005-01-13 Merck & Co., Inc. Phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor
WO2005020920A2 (en) * 2003-09-02 2005-03-10 Merck & Co., Inc. Novel crystalline forms of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor
WO2005030127A2 (en) * 2003-09-23 2005-04-07 Merck & Co., Inc. Novel crystalline form of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor
WO2006033848A1 (en) * 2004-09-15 2006-03-30 Merck & Co., Inc. Amorphous form of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor
WO2011097372A2 (en) * 2010-02-03 2011-08-11 Aptuit Laurus Private Limited Pterostilbene cocrystals
CN103408591A (en) * 2013-07-17 2013-11-27 张家港威胜生物医药有限公司 Pterostilbene phosphate disodium salt synthesis method

Also Published As

Publication number Publication date
WO2014147641A2 (en) 2014-09-25

Similar Documents

Publication Publication Date Title
EP3057430A4 (en) Processes for the preparation of pesticidal compounds
EP3057429A4 (en) Processes for the preparation of pesticidal compounds
HK1204623A1 (en) New phosphate compounds, a process for their preparation and pharmaceutical compositions containing them
IL241323B (en) Oxabicyclo [2.2.2] acid gpr120 modulators
EP3057428A4 (en) Processes for the preparation of pesticidal compounds
EP3057425A4 (en) Processes for the preparation of pesticidal compounds
EP3057431A4 (en) Processes for the preparation of pesticidal compounds
EP3057427A4 (en) Processes for the preparation of pesticidal compounds
EP3057426A4 (en) Processes for the preparation of pesticidal compounds
WO2014041560A3 (en) Process for the preparation of teneligliptin
HK1220965A1 (en) Novel abexinostate salt, associated crystalline form, preparation method thereof and the pharmaceutical compositions containing same abexinostate
FR2984870B1 (en) NEW PROCESS FOR THE PREPARATION OF PRECIPITED SILICES
WO2014125506A3 (en) A process for the preparation of ivacaftor and its intermediates
WO2016009401A3 (en) Preparation of tedizolid phosphate
EP3363803B8 (en) Urea peptoid boric acid compound, pharmaceutical composition thereof, preparation method therefor, and uses thereof
WO2014091167A3 (en) Cyclopropylboronic compounds, method for preparing same and use thereof
IL233055A (en) (1r,4r) 7-oxo-2-azabicyclo[2.2.2]oct-5-ene derivatives
EP3016935A4 (en) Process for the preparation of intermediate of dolutegravir
EP3390368A4 (en) Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine
EP3068770A4 (en) Processes for the preparation of pyrimidinylcyclopentane compounds
PL2964607T3 (en) Process for the preparation of halogen-n, n-dimethylbenzylamines
EP2997009A4 (en) Process for the preparation of arformoterol or salt thereof
WO2014159501A3 (en) Processes for preparing tetrahydroisoquinolines
WO2014030173A3 (en) Improved process for preparation of atazanavir bisulfate
WO2015001568A3 (en) Sitagliptin lipoate salt, process for the preparation and pharmaceutical composition thereof

Legal Events

Date Code Title Description
122 Ep: pct application non-entry in european phase

Ref document number: 14770990

Country of ref document: EP

Kind code of ref document: A2